Mashed on MSN

The best brewery in your state, hands down

No matter your preference when it comes to beer, we've tracked down the best brewery pouring high-quality pints in every ...
BioSpace

CatalYm Announces First Patient Dosed in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Metastatic Non-squamous NSCLC

MUNICH & SAN FRANCISCO--(BUSINESS WIRE)--CatalYm today announced that the first patient has been dosed in the randomized Phase 2b GDFATHER‑NSCLC‑02 (GDF‑15 Antibody‑MediaTed‑Human‑Effector‑T‑Cell ...
Morningstar

U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Following Priority Review, the U.S. FDA granted HYRNUO® (sevabertinib) approval for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) ...
Seeking Alpha

Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma

RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)-- Merck (MRK), known as MSD outside of the United States and Canada, and Eisai today announced results from the Phase 3 LEAP-012 trial evaluating KEYTRUDA ...
Healio

FDA approves Hernexeos as first oral therapy for NSCLC with HER2 mutations

Please provide your email address to receive an email when new articles are posted on . The FDA approved Hernexeos for adults with unresectable or metastatic HER2-mutant NSCLC. It received accelerated ...
Nasdaq

XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence

XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...
Monthly Prescribing Reference

Zanzalintinib Combo Improves OS in Non-MSI High Metastatic Colorectal Cancer

Findings showed in the ITT population, zanzalintinib plus atezolizumab statistically significantly reduced the risk of death compared with regorafenib. Topline data were announced from a phase 3 trial ...
Medscape

Updates in Metastatic Non-Small Cell Lung Cancer From ASCO 2025

Dr Jonathan Goldman, of the University of California, Los Angeles, shares key updates in metastatic non-small cell lung cancer from ASCO 2025. Dr Goldman reviews findings from TROPION-Lung02, which ...
Hosted on MSN

Day 52 – Storage Classes in Kubernetes | Static vs Dynamic Volume Provisioning

Welcome back to Day 52 of the journey! In this video, we dive deep into the essential world of persistent storage in Kubernetes, focusing specifically on storage classes. Understanding how to manage ...
TheServerSide

How Java instance main methods and unnamed classes work

Community driven content discussing all aspects of software development from DevOps to design patterns. Instance main methods and unnamed classes, coming in Java 21, will forever change how developers ...
Scientific Research Publishing

Benjamin Livshits, V. and Lam, M.S. (2005) Finding Security Vulnerabilities in Java Applications with Static Analysis. USENIX Security Symposium, 14, 18.

ABSTRACT: Security vulnerabilities are a widespread and costly aspect of software engineering. Although tools exist to detect these vulnerabilities, non-machine learning techniques are often rigid and ...